Figure 1.
Plasma concentration–time profiles of afatinib in 28 patients administered afatinib at 30 mg/day (blue solid line) or 40 mg/day (red solid line).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.